GPR120 Antibodies

Santa Cruz Biotechnology features a diverse variety of GPR120 Antibodies for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GPR120, also known as free fatty acid receptor 4 (FFA4), plays a crucial role in mediating the effects of long-chain fatty acids on metabolic processes, including insulin sensitivity and inflammation. Understanding GPR120 function is essential for advancing research in obesity and metabolic disorders, making it a significant target for therapeutic interventions. GPR120 monoclonal antibodies enable detailed investigation of receptor distribution across tissues and cells. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, provide versatile options for visualization and quantification. Studying GPR120 expression patterns helps reveal its role in metabolic regulation and inflammatory responses. Investigating GPR120 signaling pathways can lead to breakthroughs in treating metabolic diseases. Research with GPR120 monoclonal antibodies continues to advance scientific understanding of metabolic health and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to unlock new insights into GPR120 biology and its impact on human health.